Company: TGNT
Filing Date: 2025-11-17
Form Type: 10-Q
Source: 0001477932-25-008363
Chunk: 18

Company: Totaligent, Inc.
Filing Date: 2025-11-17
Form: 10-Q
Item: Part I, Item 1
Chunk 18
---
; authorized –10,000,000 shares        Series D Preferred stock, authorized –1,000,000 shares; issued and outstanding – 576,562 and 713,750 shares at September 30, 2025 and December 31, 2024, respectively  5,766   7,138 Common stock, $0.001 par value; authorized – 500,000,000 shares; 211,101,313 shares issued and 211,101,313 and 172,913,813 outstanding as of September 30, 2025 and December 31, 2024, respectively  211,101   211,101 Shares to be issued  6,093   5,476 Additional paid-in capital  58,809   818,577 Accumulated deficit  (2,298,252)  (1,807,363)Treasury stock, 0 and 38,187,500 outstanding  -   (972,181)Total stockholders' deficit  (2,016,483)  (1,737,252)Total liabilities and stockholders' deficit $285,955  $222,925 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 F-1Table of Contents

TOTALIGENT, INC.AND SUBSIDIARYCONSOLIDATED STATEMENTS OF OPERATIONSUNAUDITED    For the Three Months Ended    For the Nine Months Ended    September 30,   September 30,     2025    2024    2025    2024               Revenue $2,248  $29,990  $2,248  $444,529                  Cost of revenue  -   30,879   -   399,239                  Gross profit (loss)  2,248   (889)  2,248   45,290                  Operating expenses:                Consulting expenses  18,436   307,500   18,436   337,905 Personnel expenses  70,650   94,500   100,650   288,500 General and administrative  28,214   55,615   180,742